BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12924448)

  • 1. Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.
    Schneider-Stock R; Gerresheim F; Kolin-Gerresheim I; Meyer F; Jäger V; Epplen JT; Roessner A; Boltze C
    Pathol Res Pract; 2003; 199(6):445-50. PubMed ID: 12924448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
    J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas.
    Schneider-Stock R; Boltze C; Jaeger V; Stumm M; Seiler C; Rys J; Schütze K; Roessner A
    J Pathol; 2002 Aug; 197(5):654-60. PubMed ID: 12210086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedifferentiated liposarcoma with lipoma-like well-differentiated liposarcoma: clinicopathological study of 30 cases, with particular attention to the comingling pattern of well- and dedifferentiated components: a proposal for regrouping of the present subclassification of well-differentiated liposarcoma and dedifferentiated liposarcoma.
    Iwasa Y; Nakashima Y
    Int J Surg Pathol; 2013 Feb; 21(1):15-21. PubMed ID: 22674916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
    Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
    Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
    Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression in mixed type liposarcoma.
    Kim JI; Choi KU; Lee IS; Moon TY; Lee CH; Kim HW; Kim JY; Park DY; Sol MY
    Pathology; 2006 Apr; 38(2):114-9. PubMed ID: 16581650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of cytogenetic and molecular genetic analyses.
    Benchetritt M; Hofman V; Vénissac N; Brennetot C; Italiano A; Aurias A; Padovani B; Pedeutour F; Hofman P
    Cancer Genet Cytogenet; 2007 Dec; 179(2):150-5. PubMed ID: 18036404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
    Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
    Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.
    Boltze C; Schneider-Stock R; Jäger V; Roessner A
    Pathol Res Pract; 2001; 197(8):563-8. PubMed ID: 11518050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
    Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
    Boland JM; Colby TV; Folpe AL
    Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Adachi T; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Arch Pathol Lab Med; 2002 Sep; 126(9):1071-8. PubMed ID: 12204056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
    Thway K
    Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
    Hisaoka M; Matsuyama A; Nakamoto M
    Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
    Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
    Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation.
    Shimada S; Ishizawa T; Ishizawa K; Kamada K; Hirose T
    Virchows Arch; 2005 Nov; 447(5):835-41. PubMed ID: 16012847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
    Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
    Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma.
    Dei Tos AP; Piccinin S; Doglioni C; Vukosavljevic T; Mentzel T; Boiocchi M; Fletcher CD
    Am J Pathol; 1997 Dec; 151(6):1531-9. PubMed ID: 9403703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
    Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
    J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.